These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 9369955)
1. Cell behavior and cell-matrix interactions of human palmar aponeurotic cells in vitro. Quaglino D; Bergamini G; Croce A; Boraldi F; Barbieri D; Caroli A; Marcuzzi A; Tiozzo R; Ronchetti IP J Cell Physiol; 1997 Dec; 173(3):415-22. PubMed ID: 9369955 [TBL] [Abstract][Full Text] [Related]
2. Generation of contractile force by cultured Dupuytren's disease and normal palmar fibroblasts. Rayan GM; Tomasek JJ Tissue Cell; 1994 Oct; 26(5):747-56. PubMed ID: 9437248 [TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta1 stimulation enhances Dupuytren's fibroblast contraction in response to uniaxial mechanical load within a 3-dimensional collagen gel. Bisson MA; Beckett KS; McGrouther DA; Grobbelaar AO; Mudera V J Hand Surg Am; 2009; 34(6):1102-10. PubMed ID: 19505772 [TBL] [Abstract][Full Text] [Related]
4. [Fibronectin-chemotaxis and collagen-gel contraction of the palmar aponeurosis in morbus dupuytren]. Hoch J; Felouzis E; Meyer-Walters O; Nebe B; Notbohm H Handchir Mikrochir Plast Chir; 2002 Sep; 34(5):292-7. PubMed ID: 12494380 [TBL] [Abstract][Full Text] [Related]
5. Post-transcriptional regulation of alpha-smooth muscle actin determines the contractile phenotype of Dupuytren's nodular cells. Verjee LS; Midwood K; Davidson D; Eastwood M; Nanchahal J J Cell Physiol; 2010 Sep; 224(3):681-90. PubMed ID: 20432463 [TBL] [Abstract][Full Text] [Related]
6. Comparison of palmar aponeuroses from individuals with diabetes mellitus and Dupuytren's contracture. Melling M; Reihsner R; Pfeiler W; Schnallinger M; Karimian-Teherani D; Behnam M; Mostler S; Menzel EJ Anat Rec; 1999 Aug; 255(4):401-6. PubMed ID: 10409813 [TBL] [Abstract][Full Text] [Related]
7. Dupuytren's contracture: morphological and biochemical changes in palmar aponeurosis. Hamamoto H; Ueba Y; Sudo Y; Sanada H; Yamamuro T; Takeda T Hand; 1982 Oct; 14(3):237-47. PubMed ID: 6130030 [TBL] [Abstract][Full Text] [Related]
8. An insight into Dupuytren's contracture. Murrell GA Ann R Coll Surg Engl; 1992 May; 74(3):156-60; discussion 161. PubMed ID: 1616255 [TBL] [Abstract][Full Text] [Related]
9. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren's affected palmar fascia. Kuhn MA; Wang X; Payne WG; Ko F; Robson MC J Surg Res; 2002 Apr; 103(2):146-52. PubMed ID: 11922728 [TBL] [Abstract][Full Text] [Related]
10. Appearance of the myofibroblastic phenotype in Dupuytren's disease is associated with a fibronectin, laminin, collagen type IV and tenascin extracellular matrix. Berndt A; Kosmehl H; Katenkamp D; Tauchmann V Pathobiology; 1994; 62(2):55-8. PubMed ID: 7524526 [TBL] [Abstract][Full Text] [Related]
11. Dupuytren's disease: physiologic changes in nodule and cord fibroblasts through aging in vitro. Moyer KE; Banducci DR; Graham WP; Ehrlich HP Plast Reconstr Surg; 2002 Jul; 110(1):187-93; discussion 194-6. PubMed ID: 12087251 [TBL] [Abstract][Full Text] [Related]
12. Biochemical changes in the collagen of the palmar fascia in patients with Dupuytren's disease. Brickley-Parsons D; Glimcher MJ; Smith RJ; Albin R; Adams JP J Bone Joint Surg Am; 1981 Jun; 63(5):787-97. PubMed ID: 7240301 [TBL] [Abstract][Full Text] [Related]
13. [Alterations of cell phenotype in Dupuytren's disease--an in vitro analysis]. Docheva D; Vaerst B; Deiler S; Giunta RE; Schieker M; Volkmer E Handchir Mikrochir Plast Chir; 2012 Apr; 44(2):59-66. PubMed ID: 22495955 [TBL] [Abstract][Full Text] [Related]
14. Pharmacologic regulation of Dupuytren's fibroblast contraction in vitro. Rayan GM; Parizi M; Tomasek JJ J Hand Surg Am; 1996 Nov; 21(6):1065-70. PubMed ID: 8969433 [TBL] [Abstract][Full Text] [Related]
15. Elevated levels of beta-catenin and fibronectin in three-dimensional collagen cultures of Dupuytren's disease cells are regulated by tension in vitro. Howard JC; Varallo VM; Ross DC; Roth JH; Faber KJ; Alman B; Gan BS BMC Musculoskelet Disord; 2003 Jul; 4():16. PubMed ID: 12866952 [TBL] [Abstract][Full Text] [Related]
16. A clinical, ultrastructural and immunochemical study of Dupuytren's disease. Pasquali-Ronchetti I; Guerra D; Baccarani-Contri M; Fornieri C; Mori G; Marcuzzi A; Zanasi S; Caroli A J Hand Surg Br; 1993 Apr; 18(2):262-9. PubMed ID: 8501391 [TBL] [Abstract][Full Text] [Related]
17. Biomechanical properties of normal tendons, normal palmar aponeuroses and palmar aponeuroses from patients with Dupuytren's disease subjected to elastase and chondroitinase treatment. Millesi H; Reihsner R; Hamilton G; Mallinger R; Menzel EJ Connect Tissue Res; 1995; 31(2):109-15. PubMed ID: 15612326 [TBL] [Abstract][Full Text] [Related]
18. Abnormal behavior of cultured fibroblasts from nodule and nonaffected aponeurosis of Dupuytren's disease. Azzarone B; Failly-Crepin C; Daya-Grosjean L; Chaponnier C; Gabbiani G J Cell Physiol; 1983 Dec; 117(3):353-61. PubMed ID: 6197420 [TBL] [Abstract][Full Text] [Related]
19. The collagen changes of Dupuytren's contracture. Murrell GA; Francis MJ; Bromley L J Hand Surg Br; 1991 Aug; 16(3):263-6. PubMed ID: 1960490 [TBL] [Abstract][Full Text] [Related]
20. Fibronectin filaments and actin microfilaments are organized into a fibronexus in Dupuytren's diseased tissue. Tomasek JJ; Haaksma CJ Anat Rec; 1991 Jun; 230(2):175-82. PubMed ID: 1867394 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]